Vancouver, BC, September 28, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce its financial results for the quarter ended July 31, 2017. The Company’s financial statements for the period are available under the Company’s profile on SEDAR at www.sedar.com. All amounts are expressed in Canadian dollars.
Ontario has issued its plans for how to implement cannabis legalization once it becomes national law, and we believe there is much to champion in the province’s approach towards building a smart regulatory framework that benefits consumers, businesses and government.
As owners of cannabis grow facilities in different provinces, we are eager to begin working with regulatory bodies as they begin drafting rules. We of course fully embrace rules that provide wide latitude to consumers and businesses, but we also endorse a framework that offers clear and sturdy structure to the ways in which we conduct business, shop and consume. Ontario’s efforts reflect a legacy of hard work on the part of provincial staff and quite a bit of regulatory savvy.
This has been a long time coming.
Vancouver, BC, September 25, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that construction of the Phase 2 development, a purpose built, multiple room production facility, is well underway at its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
The foundation for the Phase 2 facility has been poured and the exterior is expected to be completed by the first part of November 2017. By the end of January 2018, the interior fit-out is expected.